GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

Year in Review 2024 - Colorectal Cancer

Oncology 2024 Year in Review

R. Kim, T. Biachi

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

1L Botensilimab + Balstilimab in Stage IV MSS CRC Without Liver Mets…

Nicholas DeVito

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

ESMO 2024 Insights: The Value of Immune Checkpoint Blockade in MSS/p…

2024 ESMO Annual Meeting Insights Hub

B. Geisler

Anti-EGFR Therapy in CRC: How to Manage Toxicities

Ibrahim Sahin

Hepatic Arterial Infusion Therapy for CRC Liver Mets and Unresectabl…

Yale Cancer Center

J. Kortmansky, S. Khan

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including TRANSM…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, K. Spencer, M. Cecchini

Treating KRAS-Mutated mCRC

Ibrahim Sahin

How Recent Data Impacts Colon and Rectal Cancer Treatment Decisions

Integrity CE

D. Mulkerin, S. Mukherjee

Guidance on Incorporating Anti-EGFR Therapy in 1L CRC Practice

Ibrahim Sahin

mCRC Case Discussion: Treatment Options for Unresectable Liver Metas…

Yale Cancer Center

P. Kunz, L. Baum, K. Du, S. Khan, J. Kortmansky

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Total Health

A. Grothey